BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 26229137)

  • 1. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.
    Stubbs JR; House JA; Ocque AJ; Zhang S; Johnson C; Kimber C; Schmidt K; Gupta A; Wetmore JB; Nolin TD; Spertus JA; Yu AS
    J Am Soc Nephrol; 2016 Jan; 27(1):305-13. PubMed ID: 26229137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
    Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
    PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction.
    Sheng Z; Tan Y; Liu C; Zhou P; Li J; Zhou J; Chen R; Chen Y; Song L; Zhao H; Yan H
    Am J Cardiol; 2019 Mar; 123(6):894-898. PubMed ID: 30594289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine
    Johnson C; Prokopienko AJ; West RE; Nolin TD; Stubbs JR
    Drug Metab Dispos; 2018 Sep; 46(9):1304-1309. PubMed ID: 29915157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
    Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethylamine N-Oxide as a Novel Therapeutic Target in CKD.
    Tang WH
    J Am Soc Nephrol; 2016 Jan; 27(1):8-10. PubMed ID: 26229138
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
    Pelletier CC; Croyal M; Ene L; Aguesse A; Billon-Crossouard S; Krempf M; Lemoine S; Guebre-Egziabher F; Juillard L; Soulage CO
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31683880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.
    Senthong V; Li XS; Hudec T; Coughlin J; Wu Y; Levison B; Wang Z; Hazen SL; Tang WH
    J Am Coll Cardiol; 2016 Jun; 67(22):2620-8. PubMed ID: 27256833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
    Kaysen GA; Johansen KL; Chertow GM; Dalrymple LS; Kornak J; Grimes B; Dwyer T; Chassy AW; Fiehn O
    J Ren Nutr; 2015 Jul; 25(4):351-6. PubMed ID: 25802017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction.
    Tan Y; Sheng Z; Zhou P; Liu C; Zhao H; Song L; Li J; Zhou J; Chen Y; Wang L; Qian H; Sun Z; Qiao S; Xu B; Gao R; Yan H
    Circ Cardiovasc Interv; 2019 Jan; 12(1):e007281. PubMed ID: 30599768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine N-oxide is associated with coronary atherosclerotic burden in non-ST-segment myocardial infarction patients: SZ-NSTEMI prospective cohort study.
    Waleed KB; Tse G; Lu YK; Peng CN; Tu H; Ding LG; Xia YL; Wu SL; Li XT; Zhou HQ; Chen QY; Sun AM; Altaf A; Chang JL; Wang LL
    Rev Cardiovasc Med; 2021 Mar; 22(1):231-238. PubMed ID: 33792267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
    Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Circulating Trimethylamine
    Flores-Guerrero JL; Osté MCJ; Baraldi PB; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethylamine
    Stubbs JR; Stedman MR; Liu S; Long J; Franchetti Y; West RE; Prokopienko AJ; Mahnken JD; Chertow GM; Nolin TD
    Clin J Am Soc Nephrol; 2019 Feb; 14(2):261-267. PubMed ID: 30665924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Plasma Trimethylamine N-Oxide Levels and Renal Dysfunction in Patients with Hypertension.
    Zhou J; Wang D; Li B; Li X; Lai X; Lei S; Li N; Zhang X
    Kidney Blood Press Res; 2021; 46(4):421-432. PubMed ID: 34233325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating trimethylamine N-oxide contributes to endothelial dysfunction in a rat model of chronic kidney disease.
    Li T; Gua C; Wu B; Chen Y
    Biochem Biophys Res Commun; 2018 Jan; 495(2):2071-2077. PubMed ID: 29247650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.